GSK (LON:GSK) Share Price Passes Above 200-Day Moving Average - Here's What Happened

Key Points

• GSK plc's stock price has crossed above its 200-day moving average, indicating a potential upswing, with shares last traded at GBX 1,448.82 ($19.47).
• Various analysts have given mixed ratings on GSK, with a current consensus rating of "Hold" and a target price averaging around GBX 1,637.50.
• Insider purchases of GSK stock suggest confidence in the company, with insiders acquiring a total of 1,913 shares valued at approximately $2.74 million in the last 90 days.

GSK plc (LON:GSK - Get Free Report) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1,430.76 ($19.30) and traded as high as GBX 1,467.50 ($19.80). GSK shares last traded at GBX 1,448.82 ($19.54), with a volume of 6,997,549 shares trading hands.

Analyst Upgrades and Downgrades

GSK has been the topic of several recent research reports. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and set a GBX 1,450 price objective on shares of GSK in a report on Thursday, July 31st. Shore Capital reaffirmed a "buy" rating and issued a GBX 2,100 target price on shares of GSK in a report on Wednesday, August 27th. JPMorgan Chase & Co. lowered their target price on shares of GSK from GBX 1,460 to GBX 1,400 and set an "underweight" rating for the company in a report on Monday, August 4th. Finally, Berenberg Bank reiterated a "hold" rating and set a GBX 1,600 price objective on shares of GSK in a research note on Friday, July 18th. One investment analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, GSK presently has a consensus rating of "Hold" and an average price target of GBX 1,637.50.

GSK Trading Down 0.8%

The company has a quick ratio of 0.73, a current ratio of 0.81 and a debt-to-equity ratio of 114.64. The company has a market cap of £58.99 billion, a P/E ratio of 1,770.86, a P/E/G ratio of 1.24 and a beta of 0.31. The business has a 50-day moving average price of GBX 1,419.99 and a two-hundred day moving average price of GBX 1,431.20.

GSK (LON:GSK - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The company reported GBX 75.30 earnings per share (EPS) for the quarter. GSK had a return on equity of 18.08% and a net margin of 8.02%. On average, analysts predict that GSK plc will post 175.980975 EPS for the current year.

Insiders Place Their Bets

In other news, insider Jonathan Symonds purchased 1,350 shares of the company's stock in a transaction dated Friday, June 20th. The stock was acquired at an average price of GBX 1,435 per share, for a total transaction of £19,372.50. Also, insider Wendy Becker acquired 545 shares of the company's stock in a transaction dated Friday, June 20th. The shares were purchased at an average price of GBX 1,435 per share, with a total value of £7,820.75. In the last 90 days, insiders have purchased 1,913 shares of company stock worth $2,744,669. 0.20% of the stock is owned by corporate insiders.

GSK Company Profile

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.